Delivering on the Promise of New Modalities: An Interview with Amber Van Laar, VP Clinical Development of AskBio

Innovation That Matters

As part of WuXi AppTec’s ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we have launched a new interview series in 2022 – […]

Delivering on the Promise of New Modalities: An Interview with Kunwoo Lee, Ph.D., CEO of GenEdit

Innovation That Matters

As part of WuXi AppTec’s ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we have launched a new interview series in 2022 – […]

An Interview with Ray Tabibiazar, M.D., CEO & Chairman of SalioGen Therapeutics

Innovation That Matters

As part of WuXi AppTec’s ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we have launched a new interview series in 2022 – […]

Delivering on the Promise of New Modalities: An Interview with David Main, President & CEO, Notch Therapeutics

Innovation That Matters

As part of WuXi AppTec’s ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we have launched a new interview series in 2022 – […]

Delivering on the Promise of New Modalities: An Interview with Sue Dillon, CEO of Aro Biotherapeutics

Innovation That Matters

New modalities offer unprecedented therapeutic potential for patients, yet they also pose unique challenges. As part of WuXi AppTec’s ongoing efforts to collaboratively foster new thinking and actionable approaches in […]

Cydan Sets the Pace for Rare Disease R&D

Innovation That Matters

As part of our ongoing interest in rare disease R&D, we interviewed Niels Svenstrup, the Senior Vice President of Development at Cydan, a virtual rare disease accelerator focused on the […]

Galera Therapeutics, Reducing Toxicity & Increasing Anti-Cancer Efficacy for Patients

Innovation That Matters

Dr. Robert Beardsley, Founder and Chief Operating Officer at Galera Therapeutics, shares his company’s R&D vision and pipeline, aimed at improving treatments and outcomes for cancer patients. Recently, Galera’s lead […]

Big Ideas Yield Transformative Results for SMA Patients: A conversation with Stuart Peltz, the Founder and CEO of PTC Therapeutics

Breakthrough Therapy

Celebrate SMA Awareness with us!  Stuart Peltz (Founder and CEO, PTC Therapeutics) shares his perspectives on the dynamics of R&D in the context of the journey that led to the […]

One-Stop Cell and Gene Therapy Solutions for Global Innovators: A Conversation with David Chang, CEO of WuXi ATU

Innovation That Matters

In the past few years, the field of cell and gene therapy has witnessed major breakthroughs. It has become one of the hottest fields in the biotech industry, with the […]

WuXi AppTec: Collaborating Against COVID-19

COVID-19

WuXi AppTec is convening and working together with experts, from our company and around the world, for ongoing analysis of the COVID-19 pandemic. We are also partnering with other industry […]

TG Therapeutics’ Early Oncology Research Leading to New MS Therapeutic

Rare Disease

Disease-Modifying RNA Therapies from Recode Therapeutics Target Rare Lung Diseases

Rare Disease

Episode I: Tackling Alzheimer’s Disease with Scale, System & Speed

Events

Please click on the banner image above to watch the dialogue. “I believe by 2040, we will begin to demonstrate significant efforts that will prevent this disease, where we prevent […]

Episode II: Building Paths Towards Healthy Aging Through Innovation: An Industry Perspective

Events

Please click on the banner image above to watch the dialogue. “What we understand is that these diseases begin very early in life. They don’t suddenly occur when you’re in […]

Episode III: The Future of Aging: Challenges & Opportunities

Events

Please click on the banner image above to watch the dialogue. “The most important thing that we can accomplish in the next number of years, and I certainly hope we […]

Episode IV: How Research & Education Can Impact an Aging Society: A Singapore Perspective

Events

Please click on the banner image above to watch the dialogue. “We’re in the age of precision medicine. I think we need to move into precision health promotion, precision medical […]

DMD: Charting the Path for New Therapeutics and Better Care

Events

Dear colleagues and friends, Thank you for participating in our global webinar, “Duchenne Muscular Dystrophy: Charting the Path for New Therapeutics and Better Care,” which was co-organized with Parent Project Muscular […]

Fragile X Syndrome: In Pursuit of a Cure

Events

Dear colleagues and friends, A global webinar titled “Fragile X Syndrome: In Pursuit of a Cure,” took place on July 22 to commemorate World Fragile X Day. This complimentary event […]

Winning the War on Huntington’s Disease

Events

In honoring Huntington’s Disease Awareness Month, WuXi AppTec is proud to host the “Winning the War on Huntington’s Disease” webinar to raise awareness and increase understanding of this rare and […]

Progress in Halting Pompe Disease

Events

Dear Colleagues and Friends, In commemorating International Pompe Day on April 15, we are proud to host a special webinar, “Progress in Halting Pompe Disease,” to raise awareness of not […]

WuXi Rare Disease Awareness Concert 2021

Events

Dear Colleagues and Friends, On February 28th each year, people around the world commemorate Rare Disease Day in honor of the patients, caregivers and medical professionals who contend with these […]

WuXi Healthcare Forum 2021

Events

Dear Colleagues and Friends, The much anticipated WuXi Healthcare Forum 2021 premiered on March 15-18th. This complimentary and global event titled, “Partnership for Patients,” brought together 6,000+ registrations, 70+ distinguished […]

Emerging Opportunities in Multiple Sclerosis and Neurosciences

Events

Can we build a roadmap to conquer Multiple Sclerosis (MS), a disease that impacts more than 2 million globally as the leading non-traumatic disability disorder in young adults?

Rare Disease: Spinal Muscular Atrophy

Events

August is the month each year when special efforts are made to raise awareness of patients suffering from Spinal Muscular Atrophy (SMA), a crippling, degenerative neuromuscular disease. In its most severe form, SMA is the leading genetic cause of infant death. WuXi AppTec welcomes the opportunity to contribute to SMA Awareness Month this year..

WuXi Global Forum 2021

WuXi Global Forum

This year, the ninth annual WuXi Global Forum premiered virtually and concurrently during the J.P. Morgan Healthcare Conference week. With the theme of “Advancing Breakthroughs for Patients,” this year’s Forum […]

WuXi Global Forum 2020

WuXi Global Forum

Now in its eighth year, the WuXi Global Forum at the J.P. Morgan Healthcare Conference brings together thousands of leaders to promote new thinking on a global stage as we […]

WuXi Global Forum 2019

WuXi Global Forum

Into its seventh year, WuXi Global Forum 2019 continues its tradition of bringing together thousands of leaders onsite and via live broadcasting to promote new thinking on a global stage.

WuXi Global Forum 2018

WuXi Global Forum

Now in its sixth year, WuXi Global Forum 2018 takes place during the J.P. Morgan Healthcare Conference, with industry thought leaders discussing rapid advancements and changes impacting the industry, from […]

WuXi Global Forum 2017

WuXi Global Forum

WuXi Global Forum 2017, now in its fifth year, brings together 1,000 industry leaders to find transformative models and solutions for patients, at a time when stakes are higher than […]

WuXi Global Forum 2016

WuXi Global Forum

The life science industry is entering a renewed age of innovation in 2015. Collectively, we have delivered strong results on almost every front, buoyed by breakthrough therapies and scientific advancements. […]

WuXi Global Forum 2015

WuXi Global Forum

To many, 2014 is a year of renewed energy and growth. Global partnerships at all levels are breaking down barriers to innovation, as the convergence of health and technology starts […]

WuXi Global Forum 2014

WuXi Global Forum

2013 has been a great year in the world of pharmaceutical and biotech R&D. While we are still facing mounting productivity challenges, many have come to understand that any single […]

WuXi Global Forum 2013

WuXi Global Forum

January 8, 2013 | Grand Hyatt San Francisco China is the world’s 3rd largest pharmaceutical market, 2nd largest economy, and the largest population with unmet medical needs. The “Gateway to […]

WuXi ATU & Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies

WuXi News

WuXi ATU and Wugen announce manufacturing partnership to expedite the delivery of novel cell cancer immunotherapies. WuXi ATU will provide manufacturing and testing services for Wugen’s WU-NK-101, a novel immunotherapy […]

WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics

WuXi News

SHANGHAI, April 8 2022 — WuXi AppTec, a leading global provider of R&D and manufacturing services that enables the global pharmaceutical and healthcare industry, received an ESG Risk Rating, recognizing […]

WuXi Healthcare Forum 2022

WuXi News

Dear Colleagues and Friends, We are delighted to announce that registration is now open for WuXi Healthcare Forum 2022, which will premiere on April 26-28, 2022. The event is virtual, […]

Life Sciences Night at the Opera 2022

Community

Join us in supporting the San Diego Opera’s Life Sciences Night program! The 2022 Life Sciences Night at the Opera is an elegant event that brings together the San Diego’s […]

WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan

Community

SHANGHAI, December 8, 2021 — WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry, announced that it is a recipient […]

WuXi AppTec Receives AA ESG Rating from MSCI

Community, WuXi News

WuXi AppTec upgraded to an AA environmental, social and governance (ESG) rating by Morgan Stanley Capital International Shanghai, September 5, 2021 – WuXi AppTec (“the Company”) is pleased to announce […]

WuXi AppTec Reports Strong 2021 Interim Results

Community, WuXi News

Revenue Up 45.7% Year-Over-Year to RMB10,537 Million Net Profit Attributable to Owners of the Company Up 55.8% Year-Over-Year to RMB2,675 Million Diluted EPS Up 46.8% Year-Over-Year to RMB0.91 Adjusted Non-IFRS[1] […]

WuXi STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland

Community

State-of-the-art facility significantly enhances WuXi STA’s drug product capacity in Europe while better enabling global customers New York & Shanghai, 3rd August, 2021: WuXi STA – a subsidiary of WuXi […]

WuXi STA Chooses Middletown Delaware for New Pharmaceutical Manufacturing Campus

Community, WuXi News

WuXi STA bringing about 500 jobs to Middletown WILMINGTON, Del. (June 28, 2021) — WuXi STA and Delaware Prosperity Partnership today announced that WuXi STA, a leading Contract Development and […]

Next Act: Europe-China Collaborations during West-East Roundtable

Community

REGISTER NOW 21st Bio€quity Europe | Register Now and Receive 15% Discount, compliments of WuXi AppTec |  May 17-19, 2021, Digital Event Can cross-border deals between Europe and China turn […]

WuXi AppTec Reports Strong 2020 Annual Results

WuXi News

Revenue Up 28.5% Year-over-Year to RMB16,535 Million Net Profit Attributable to Owners of the Company Up 59.6% Year-over-Year to RMB2,960 Million Diluted EPS Up 56.3% Year-over-Year to RMB1.25 Adjusted Non-IFRS […]

WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland

WuXi News

NEW YORK & SHANGHAI — Bristol Myers Squibb (NYSE: BMY) and WuXi STA – a subsidiary of WuXi AppTec – today announced that WuXi STA has agreed to purchase Bristol […]